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Abstract
Background: Exposure to the nerve agent soman (GD) causes neuronal cell death and impaired behavioral
function dependent on the induction of status epilepticus (SE). Little is known about the maturation of this
pathological process, though neuroinflammation and infiltration of neutrophils are prominent features. The purpose
of this study is to quantify the regional and temporal progression of early chemotactic signals, describe the cellular
expression of these factors and the relationship between expression and neutrophil infiltration in damaged brain
using a rat GD seizure model.
Methods: Protein levels of 4 chemokines responsible for neutrophil infiltration and activation were quantified up
to 72 hours in multiple brain regions (i.e. piriform cortex, hippocampus and thalamus) following SE onset using
multiplex bead immunoassays. Chemokines with significantly increased protein levels were localized to resident
brain cells (i.e. neurons, astrocytes, microglia and endothelial cells). Lastly, neutrophil infiltration into these brain
regions was quantified and correlated to the expression of these chemokines.
Results: We observed significant concentration increases for CXCL1 and MIP-1a after seizure onset. CXCL1
expression originated from neurons and endothelial cells while MIP-1a was expressed by neurons and microglia.
Lastly, the expression of these chemokines directly preceded and positively correlated with significant neutrophil
infiltration in the brain. These data suggest that following GD-induced SE, a strong chemotactic response
originating from various brain cells, recruits circulating neutrophils to the injured brain.
Conclusions: A strong induction of neutrophil attractant chemokines occurs following GD-induced SE resulting in
neutrophil influx into injured brain tissues. This process may play a key role in the progressive secondary brain
pathology observed in this model though further study is warranted.
Background
Soman (pinacolyl methylphosphonofluoridate, GD) is a
G-series nerve agent that rapidly and irreversibly binds
to acetylcholinesterase, causing excess acetylcholine
accumulation in the central and peripheral nervous sys-
tems, which results in cholinergic crisis. A consequence
of this cholinergic crisis is rapid induction of status epi-
lepticus (SE) that can continue unabated for many
hours [1]. The duration of this seizure activity increases
the magnitude of neuropathology [2,3] with the hippo-
campus, amygdala, thalamus and piriform cortex being
the most severely affected [4,5]. Although initial injury
occurs rapidly, a robust neuroinflammatory response
can exacerbate damage to the brain over time. Neuroin-
flammation is a key factor in pathology development in
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agent-induced seizure [8-11].
An early component of neuroinflammation is the
recruitment and activation of circulating neutrophils to
areas of injury. Neutrophil infiltration is an important
step in the development of neuropathology following sei-
zure [6,12,13]. Once through the blood-brain barrier, the
respiratory burst of neutrophils can exacerbate the initial
injury through indiscriminate protease damage to sur-
rounding healthy tissues [14]. Infiltrating neutrophils are
directed to and activated in injured brain regions by che-
mokines. For example, the chemokine (C-X-C motif)
ligand 1 (CXCL1 or GRO KC) directs neutrophils to
injured tissues [15] and propagates the neuroinflamma-
tory response by inducing thes y n t h e s i so fa c u t ep h a s e
response cytokines interleukin (IL)-1, IL-6 and tumor
necrosis factor-a in those cells [16]. Similarly, macro-
phage inflammatory protein (MIP)-1a functions to
recruit and activate granulocytes (including neutrophils)
in damaged brain regions [17-19]. Because inflammatory
chemokines are up-regulated in many SE models [20-22],
these factors likely play a role in this model as well.
Most studies of neuroinflammation following seizuro-
genic nerve agent exposure have centered on transcript
changes [8,23,24] or limited protein changes [10].
Recently, however, we have reported the upregulation of
multiple acute phase cytokines in this GD model [11].
In this study, we quantified the protein levels of the
neutrophil chemoattractant and activating factors
CXCL1, MIP-1a, granulocyte colony stimulating factor
(G-CSF) and granulocyte-macrophage colony stimulat-
ing factor (GM-CSF), using multiplex immunoassays in
brain tissue lysates following GD exposure up to 72
hours after SE onset. Additionally, cell-specific chemo-
kine expression and neutrophil infiltration were investi-
gated in damaged brain regions (i.e. piriform cortex,
hippocampus and thalamus). CXCL1 and MIP-1a con-
centrations were significantly increased in all three brain
regions investigated, while no change was observed in
G-CSF or GM-CSF. CXCL1 and MIP-1a predominantly
localized to neurons and either endothelial cells
(CXCL1) or microglia (MIP-1a). Expression also pre-
ceded and positively correlated to significant neutrophil
infiltration in these brain regions. These data are the
first to show upregulation and cellular expression of
chemokines and the ensuing influx of neutrophils in
damaged brain regions following GD-induced SE.
Methods
GD seizure model
This model has been described previously [11,25].
Briefly, adult male Sprague-Dawley rats (Charles River
Laboratories, Wilmington, MA; CRL: CD[SD]-BR, 250 -
350 g) were treated with HI-6 dichloride (1-(((4-
(aminocarbonyl)pyridinio) methoxy)methyl)-2-((hydro-
xyimino)methyl)pyridinium dichloride)(BN44621, Starks
Associates, Buffalo, NY; 125 mg/kg, i.p.) 30 minutes
prior to GD administration and with atropine methyl
nitrate (AMN, Sigma-Aldrich, St. Louis, MO; 2.0 mg/kg,
i.m.) 1 minute after GD administration. Vehicle control
animals received HI-6, AMN and saline, while naïve ani-
mals received no injections. GD (GD-U-2323-CTF-N,
purity 98.8 wt%) was diluted in saline at the United
States Army Medical Research Institute of Chemical
Defense (USAMRICD) and administered subcutaneously
(1.6 LD50 = 180 μg/kg). The experimental protocol was
approved by the Animal Care and Use Committee at
USAMRICD, and all procedures were conducted in
accordance with the principles stated in the Guide for
the Care and Use of Laboratory Animals (National
Research Council, 1996), and the Animal Welfare Act of
1966 (P.L. 89-544), as amended. The animal care pro-
gram at this institute is fully accredited by the Associa-
tion for Assessment and Accreditation of Laboratory
Animal Care International.
Multiplex bead array immunoassay
As previously described [11], piriform cortex, hippocam-
pus and thalamus brain tissue samples were procured
from experimental and vehicle control animals at 0.5, 1,
3, 6, 12, 24, 48 or 72 hours after onset of convulsions.
Tissue lysates were produced by first rinsing the excised
tissue with cold PBS followed by snap freezing in liquid
nitrogen. A ratio of 1 ml ice-cold triple detergent lysis
buffer containing a Complete™ protease inhibitor cock-
tail (Roche Biochemicals, Indianapolis, IN) to 50 mg of
frozen tissue was used for homogenization. Two 30 sec
pulses on a mini Beadbeater (Biospec Products Inc., Bar-
tlesville, OK) using 3.2 mm stainless steel beads were
used to homogenize the tissue. Samples were centri-
fuged at 8000 × g for 5 minutes to separate the lysate
from the tissue pellet. Rat cytokine multiplex bead
immunoassay kits were used to quantify the concentra-
tions of CXCL1 (GRO KC), MIP-1a,G - C S Fa n dG M -
C S F( L I N C OR e s e a r c h ,S t .C h a r l e s ,M O ) .I n d i v i d u a l
standard curves were generated in duplicate using the
supplied reference chemokine concentrations according
to the manufacturer’s instructions. A volume of 25 μlo f
sample (94 ± 8 μg protein) per well, assayed in dupli-
cate, was used for data generation. The plate was read
on a Bioplex™ 100 instrument (Bio-Rad Laboratories,
Hercules, CA) and analyzed with either BioRad or
STaRStation software (Applied Cytometry, Sacramento,
CA). Values that were calculated by the assay to be
below the minimum detectable concentration (MinDC)
for that particular analyte were conservatively estimated
to be the MinDC value minus 0.01 pg/ml for statistical
analysis. The number of replicates for the experimental
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time point and naïve; hippocampus, n = 6 for each time
point except for naïve (n = 5), 6 hr (n = 5) and 24 hr (n
= 7); and thalamus, n = 5 for each time point and naïve
except for 0.5 hr (n = 6), 6 hr (n = 4), 12 hr (n = 3), 24
hr (n = 6) and 48 hr (n = 6). Time matched vehicle con-
trols (n = 3 per time point) were analyzed individually
and condensed into a single vehicle control comparison
group when no significant statistical difference was
found between these samples over time by analyte or
brain region.
Immunohistochemistry (IHC)
Separate from the animals used in the multiplex bead
array immunoassay, experimental, vehicle control and
naïve animals were deeply anesthetized and perfused
with isotonic saline followed by 4% paraformaldehyde
via cardiac puncture. Brains were processed and sec-
tioned at 40 microns as previously described [11]. The
12 hour time point was selected based on the peak
expression times of the analytes from the multiplex
assays. Free float fluorescent IHC labeling was con-
ducted as previously described [26]. The antibodies
used were as follows: rabbit anti-Gro a (CXCL1) (1:100;
ab9772), rabbit anti-MIP-1a (1:500, ab9781) and mouse
anti-rat endothelial cell antigen (RECA,1:1000; ab9774)
from Abcam (Cambridge, MA), mouse anti-NeuN to
label neurons (1:1000; MAB377) and mouse anti-CD11b
to label microglia and macrophages (1:1000; CBL1512)
from Chemicon (Temecula, CA), and mouse anti-GFAP
to label astrocytes (1:1000; MS-280-P) from NeoMarkers
(Fremont, CA). Alexafluor™ fluorescent-tagged second-
ary and tertiary antibodies (Molecular Probes, Eugene,
OR) were used for visualization. Tissue sections labeled
with only secondary and tertiary antibodies were used
as controls. Sections were viewed and digitally captured
with an Olympus BX51 microscope equipped with an
Olympus DP-70 high-resolution color CCD digital cam-
era (Opelco, Dulles, VA). An Olympus BX61 equipped
with a DSU spinning disk confocal system and DP-70
CCD camera and a Zeiss LSM 700 confocal microscope
were used for subsequent IHC micrographs to confirm
same cell co-localization. Images of 40-μm tissues were
acquired using a z step interval of 1 μm and analyzed
using Slidebook™ (Olympus) or Zen 2009 (Zeiss) soft-
ware. Publication images were compiled using Adobe
Photoshop CS digital image software. Color levels and
background labeling were reduced and evened using the
“levels” tool. All input levels (0-255) were normalized in
the RGB channel as follows: highlight input levels were
set at the peak of the image histogram, midtone levels
were set at 0.8 and shadow levels were set either at the
edge of the histogram closest to 255 or at 180, which-
ever was greater. This technique was successful at
reducing background while not oversaturating specific
labeling. For all time points, n = 3.
Quantitative Stereology
Sections were labeled with Mayer’s hematoxylin/eosin-
phloxine stain. Infiltrating neutrophils were visually
identified by the user and quantified within the piriform
cortex, hippocampus and thalamus using Stereologer
2000 software (Stereology Resource Center, Chester,
MD) on an Olympus BX51 microscope equipped with
an IK-C44H CCD Toshiba camera (Imaging Planet,
Goleta, CA). Four to eight sections from tissue slabs of
approximately 1440 to 3300 μm in length were used for
counting in each case. Estimates used the optical fractio-
nator method. For each tissue section analyzed, section
thickness was assessed empirically and guard zones 2
μm thick were used at the top and bottom of each sec-
tion. The tissue regions were outlined using 10 × magni-
fication, and cells were counted using 40 ×
magnification. Approximately 50% of the outlined region
was analyzed using a systematic random sampling
design with a counting frame size of 175 μm and a dis-
ector height of 7 μm. The coefficients of error (CE)
were calculated by the software and maximum CE was
set at 0.1600.
Statistical Analysis
Immunoassay data were evaluated by one-way ANOVA
with a post-hoc Dunnett’sa n a l y s i sa n de x p r e s s e di np g /
ml. Neutrophil stereology data were evaluated by one-
way ANOVA with a post-hoc Newman-Kuel analysis
a n de x p r e s s e da sc e l l s / m m
3. A Pearson’sc o r r e l a t i o n
coefficient using a one measurement time lag between
CXCL1 or MIP-1a concentration and neutrophil infil-
tration was also calculated. The one measurement time
lag was used due to the many downstream molecular
events that occur following neutrophil exposure to these
chemokines that allow the neutrophil to traverse the
vasculature into the injured tissue. Values are expressed
as mean ± SEM. Differences were considered significant
at the level of p ≤ 0.05.
Results
Brain concentrations of CXCL1 significantly increase in
response to GD-induced SE
Temporal and regional changes in CXCL1, MIP-1a,
G-CSF and GM-CSF protein concentrations were
determined using a bead-based multiplex immunoas-
say on tissue lysates from the piriform cortex, hippo-
campus and thalamus. CXCL1 and MIP-1a
significantly increased in all brain regions investigated.
G-CSF and GM-CSF concentrations did not signifi-
cantly change and were not analyzed further (data not
shown).
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three brain regions (Figure 1). The highest concentra-
tions were in the hippocampus, where concentrations
significantly increased by 6 hours (4674 ± 1504 pg/ml)
and peaked by 12 hours (8441 ± 2152 pg/ml vs. 58 ± 6
pg/ml in vehicle controls) following GD-induced SE. In
the piriform cortex, CXCL1 levels peaked at 6 hours
(1164 ± 195 pg/ml) and remained significantly elevated
up to 24 hours (501 ± 176 pg/ml) compared to vehicle
controls (49 ± 9 pg/ml). In the thalamus, CXCL1 con-
centration became significant at 12 hours compared to
controls (4571 ± 643 pg/ml vs. 50 ± 3 pg/ml).
CXCL1 is expressed by neurons and endothelial cells
Twelve hours following GD-induced SE, CXCL1 immu-
nolabeling was present in the piriform cortex (Figure
2A, left), hippocampus (dentate gyrus shown; Figure 2B,
left) and thalamus (Figure 2C, left), while CXCL1 label-
ing was absent in vehicle controls in the same regions
(Figure 2A, B, &2C, right). Specific labeling was also
absent in secondary only controls at the 12-hour time
point (Figure 2D) and in vehicle controls (Figure 2E) as
exemplified by the piriform cortex. In the piriform cor-
tex, CXCL1-positive cells were found predominantly in
layer II but also in layer III. In the hippocampus,
CXCL1-positive cells were found primarily in the granu-
lar layer of the dentate gyrus (GrDG) and the CA3 pyra-
midal layer closest to the dentate gyrus. CXCL1-positive
cells were also found in the laterodorsal and lateral pos-
terior nuclei of the thalamus. To identify these cells,
sections were co-labeled with antibodies specific for
neurons, astrocytes, microglia and endothelial cells and
for CXCL1. CXCL1 immunoreactivity was found in
neuronal populations in the regions mentioned above
(Figure 2F). CXCL1 diffusely labeled the cytoplasm in
these cells with interspersed fine punctate labeling. No
co-localization was observed between CXCL1 and astro-
cytes (Figure 2G) or microglia (Figure 2H) regardless of
state of activation. Co-localization was limited in
endothelial cells, though a prevalent, but not exclusive,
association between CXCL1 and the vasculature was
often observed (Figure 2I).
Brain concentrations of MIP-1a significantly increase in
response to GD-induced SE
Significant concentration increases were observed for
MIP-1a protein in all three brain regions following GD-
induced seizure (Figure 3). MIP-1a concentrations signif-
icantly increased in the hippocampus at 6 hours (152 ±
42 pg/ml), peaked at 24 hours (247 ± 90 pg/ml) and then
rapidly decreased by 48 hours after SE onset compared to
vehicle controls (2.06 ± 0.05 pg/ml). In the piriform cor-
tex, MIP-1a concentrations significantly increased at 3
hours (149 ± 14 pg/ml), peaked at 24 hours (200 ± 34
pg/ml) and remained elevated through the 72-hour end-
point (139 ± 22 pg/ml) compared to vehicle controls
(<1.94 pg/ml, MinDC). The pattern in the thalamus was
different still, where a double peak was observed at 12
hours (245 ± 28 pg/ml) and 48 hours (248 ± 22 pg/ml)
compared to controls (18 ± 11 pg/ml).
MIP-1a is expressed by neurons and microglia
Twelve hours following seizure onset, MIP-1a immuno-
labeling was present in piriform cortex (Figure 4A, left),
hippocampus (dentate gyrus shown; Figure 4B, left) and
thalamus (Figure 4C, left) but not in vehicle controls
(Figure 4A, B &4C, right). Weak to moderate diffuse co-
localization with neurons (Figure 4D) was observed in
layers II and III of the piriform cortex, the CA1 and
CA3 pyramidal layers of the hippocampus and the poly-
morphic (PoDG) but not the granular layer (GrDG) of
the dentate gyrus. Astrocytes were not found to express
MIP-1a in any region observed (Figure 4E). Activated
microglia strongly expressed MIP-1a in all regions
investigated. These cells had a myriad of morphological
features including hypertrophy, spheroid shape, blebbing
and dystrophy. Specifically, MIP-1a shows a high degree
of cellular localization with the dystrophic microglial
morphology (Figure 4F). Lastly, MIP-1a-positive cells
were closely associated with large blood vessel endothe-
lial cells in the piriform cortex and thalamus but co-
localization was not observed (Figure 4G).
Neutrophil influx positively correlates with chemokine
expression
To determine whether neutrophil recruitment correlates
to increases in CXCL1or MIP-1a, neutrophil counts in
Figure 1 CXCL1 increases in rat brain after GD-induced SE.
Concentrations of CXCL1 peak at 6 hours in the piriform cortex
(solid gray line) and 12 hours in the hippocampus (solid black line)
and thalamus (open gray line). Data are given as pg/ml of tissue
lysate and reported as mean ± SEM. Data were analyzed using a
one-way ANOVA with a post-hoc Dunnett’s analysis comparing to
vehicle control. (
## p < 0.01 hippocampus, * p < 0.05, ** p < 0.01
piriform cortex,
$$ p < 0.01 thalamus).
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quantified using stereological techniques and correlated
to CXCL1 and MIP-1a concentration data using a one
measurement time lag with Pearson’s correlation analy-
sis. Neutrophil infiltration significantly increases in all
three observed brain regions following GD-induced SE
(Figure 5). No neutrophils were found in vehicle con-
trols in any brain region (0 ± 0 cells/mm
3). In the piri-
form cortex, neutrophil infiltration significantly
increased at 12 (1,117 ± 485 cells/mm
3) and 24 hours
(1,565 ± 618 cells/mm
3) but not 6 hours (3 ± 5.8 cells/
mm
3) compared to vehicle. Significant, though less
Figure 2 CXCL1 is expressed in neurons and, to a much lesser extent, in endothelial cells after GD-induced SE. Prominent CXCL1 (A-I,
green) immunolabeling is present in the piriform cortex, hippocampus and thalamus 12 hours after GD-induced SE (A, B & C; left). CXCL1 is
absent in vehicle controls of these same regions (A, B & C; right). In the piriform cortex (A), labeling is observed primarily in layers II and III. In
the hippocampus (B), labeling was primarily confined to the CA3 pyramidal layer and granular layer of the dentate gyrus (GrDG) but not evident
in the polymorphic layer of the dentate gyrus (PoDG). CXCL1 was located to the laterodorsal and lateral posterior nuclei of the thalamus (C).
Labeling was absent in the secondary controls for both 12-hour GD-exposed (D) and vehicle control tissues (E), exemplified by the piriform
cortex. Neurons (F, red) and CXCL1 were often found to co-localize (F, yellow). Co-localization was not observed in hypertrophic astrocytes (G,
red) or activated microglia (H, red) and was limited in endothelial cells (I, yellow). DAPI (A-I, blue) was used to label the nuclei of each cell. Scale
bar: 250 μm (A-E), 50 μm and 20 μm (F-I) for regular and confocal fluorescent microscopy respectively; n = 7 for 12-hour, n = 4 for vehicle
controls.
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hippocampus at 12 (128 ± 85 cells/mm
3)a n d2 4h o u r s
(589 ± 10 cells/mm
3) but not 6 hours (0 ± 0 cells/mm
3)
compared to vehicle. In contrast, neutrophils in the tha-
lamus significantly increased only at 24 hours (2,098 ±
824 cells/mm
3)a n dn o ta t1 2h o u r s( 1 5 8±9 0c e l l s /
mm
3). Pearson’s correlation analysis revealed a positive
correlation between CXCL1 concentration and neutro-
phil infiltration (offset by one time point) in the piriform
cortex, hippocampus and thalamus. For MIP-1a,al e s s
robust positive correlation existed in the hippocampus
and thalamus compared to CXCL1. No significant corre-
lation was observed in the piriform cortex (Table 1).
Discussion
Neuroinflammation is almost ubiquitous following brain
injury, though little is known about this process follow-
ing damage caused by GD-induced SE. As part of the
inflammatory process, resident and systemic inflamma-
tory cells migrate to areas of injury guided by concen-
tration gradients of chemokines and growth factors.
This study describes the temporal and regional protein
changes of four neutrophil activating and chemotactic
factors in the brain, the expression of significantly upre-
gulated factors in resident brain cells, quantification of
neutrophil infiltration into the brain, and the correlation
between chemokine expression and neutrophil infiltra-
tion. Significant expression of two chemokines, CXCL1
and MIP-1a, immediately preceded neutrophil infiltra-
tion in brain regions damaged by SE (i.e., the piriform
cortex, hippocampus and thalamus). Both chemokines
were primarily expressed by neurons; however, CXCL1
was also expressed in endothelial cells, and MIP-1a was
also expressed in activated microglia. These data are the
first to show the temporal, regional and cellular protein
expression of chemokines, consequent neutrophil infil-
tration and the relationship between these two events
following nerve agent exposure and subsequent SE.
Of all the resident brain cell types, neurons appear
most susceptible to GD-induced SE damage as shown
by substantial neuronal cell death in the piriform cortex,
thalamus and portions of the hippocampus [5,27].
Therefore, it is not surprising that neurons become the
focal point of the inflammatory response. In fact, the
neurons most vulnerable to GD-induced SE, including
those in layer II of the piriform cortex [28], strongly
expressed both CXCL1 and MIP-1a. Injured neurons
have the ability to produce chemokines to recruit and
activate inflammatory cells following injury [29-31], and
we have now shown expression of CXCL1 and MIP-1a
in the GD-induced SE model as well.
Astrocytes did not express CXCL1 or MIP-1a in any
brain region despite concurrent neuronal injury. CXCL1
expression by astrocytes does occur following various
central nervous system (CNS) insults [32-34], and this
expression appears to be dependent on neuronal
damage [35]. Similarly, MIP-1a is expressed by astro-
cytes in SE [36] and experimental autoimmune encepha-
lomyelitis models [37,38]. Though it is unknown exactly
why chemokine expression in this model is incongruent
with other CNS injury paradigms, it is apparent that
chemokine expression is likely insult specific [39], and
neutrophil recruitment may not be the main function of
astrocytes in this model or at this point in pathology
progression. Further, cytokine expression is prominent
in both astrocytes (IL-6) and microglia (IL-1) in this
model and may function to modulate the neuroinflam-
matory process rather than to recruit inflammatory cells
[11].
Despite a lack of expression in most microglia, MIP-1a
was expressed by a number of activated microglia and
p r o m i n e n t l ye x p r e s s e db yt h o s ew i t had y s t r o p h i cm o r -
phology. MIP-1a expression by active microglia following
brain injury has been previously observed [40], though
little is known about dystrophic microglia or the expres-
sion of inflammatory factors by this morphological type.
It is known that dystrophic microglia appear exclusively
in progressive neurodegenerative disease states such as
Alzheimer’s and Huntington’s disease and are indicative
of concurrent and subsequent neuronal degeneration
[41-43], a condition that is accelerated in this model. We
have previously shown that another important neutrophil
chemoattractant [44] and upregulator of neutrophil infil-
tration endothelium adhesion molecules [45], IL-1b,w a s
also localized to dystrophic microglia [11]. Therefore,
dystrophic microglia appear to have a prominent role in
Figure 3 MIP-1a Increases in Rat Brain after GD-induced SE.
MIP-1a concentrations significantly increase in the hippocampus,
piriform cortex and thalamus following GD-induced SE. MIP-1a
concentrations peak at 24 hours after seizure onset in both the
hippocampus (solid black line) and piriform cortex (solid gray line).
In the thalamus (open gray line), there is a double peak at 12 and
48 hours after seizure onset. Data are given as pg/ml of tissue lysate
reported as mean ± SEM. Data were analyzed using a one-way
ANOVA with a post-hoc Dunnett’s analysis comparing to vehicle
control. (
# p < 0.05,
## p < 0.01 hippocampus; ** p < 0.01 piriform
cortex;
$ p < 0.05,
$$ p < 0.01 thalamus).
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prolonged SE induced by GD.
Lastly, significant CXCL1 expression precedes a signif-
icant influx of neutrophils into vulnerable brain regions
(<6 hours in the piriform cortex and hippocampus and
<12 hours in the thalamus; Figures 1 &5). A less defini-
tive positive correlation exists for MIP-1a, likely because
MIP-1a is highly pleiotropic and also modulates the
chemotaxic and activation properties of other leukocyte
cell types [46,47]. Though there is a strong positive
correlation between CXCL1 concentration and conse-
quent neutrophil influx, this relationship does not
appear to be proportional. For example, while we
observed the highest concentrations of CXCL1 in the
hippocampus, this region had the fewest number of
infiltrating neutrophils. In contrast, the piriform cortex
had the lowest concentration of CXCL1 but had some
of the highest numbers of infiltrating neutrophils.
Though little is known about regional differences in
brain chemokine expression, there are several variables
Figure 4 MIP-1a is primarily expressed by neurons and dystrophic microglia after GD-induced SE. MIP-1a immunolabeling (A-G, green) is
present in the piriform cortex, hippocampus and thalamus 12 hours after GD-induced SE (A, B & C; left) but absent in vehicle controls of these
same regions (A, B & C; right). In the piriform cortex (A), labeling is observed primarily in layers II and III. In the hippocampus (B), labeling was
less robust and found primarily in the CA1 and CA3 pyramidal layers as well as in the polymorphic layer of the dentate gyrus (PoDG) but not
the granular layer of the dentate gyrus (GrDG). MIP-1a labeling was also less robust in the thalamus (C) and was found primarily in the
laterodorsal and lateral posterior nuclei. Neurons (D, red) and MIP-1a frequently co-localized (D, yellow), while no co-localization with astrocytes
(E, red) was observed. MIP-1a was primarily expressed by microglia with a dystrophic morphology (F, red). Limited co-localization was observed
in endothelial cells (G, red). Scale bar: 250 μm (A-C), 50 μm and 10 μm (D-F) for regular and confocal fluorescent microscopy respectively; n = 9
for 12-hour and n = 4 for vehicle controls.
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concentration and neutrophil infiltration. First, region
specific neutrophil infiltration may rely on other cyto-
kine induced neutrophil chemoattractant (CINC) family
members. For example, CXCL1, also known as CINC-
2b, was not found to be a major contributing factor in
brain neutrophil infiltration following direct IL-1b injec-
tion into the brain compared to CINC-1 and CINC-2a
[ 4 8 ] .I ts h o u l db en o t e d ,h o w e v e r ,t h a ti n d i v i d u a lc h e -
mokine involvement is likely injury specific and these
CINCs may not be active in this model. Second, differ-
ential IL-1b brain expression may play a role. We have
previously documented regional differences in brain IL-
1b concentration, an important promoter of neutrophil
adhesion, in this model [11]. No significant expression
of IL-1b was observed in the hippocampus whereas sig-
nificant increases in IL-1b were observed in the piriform
cortex and thalamus that correspond to neutrophil
i n f l u x .H o w e v e r ,I L - 1 a, an IL-1 isoform that can
similarly increase CXCL1 expression and cellular adhe-
sion molecules [49], was significantly increased and may
serve a similar role as IL-1b in this model. Lastly, differ-
ential expression of CXCL1 receptors, CXCR1 and
CXCR2, and the associated vascular cell surface glycosa-
minoglycans (GAGs), may account for the observed dis-
crepancy between CXCL1 expression and neutrophil
infiltration. GAGs are essential for forming chemotactic
gradients [50] and affect chemokine binding to their
associated G-protein-coupled receptors [51]. Because
different chemokines bind with varying affinities to dif-
ferent GAGs [50] and GAG and CXCL1 receptor
expression are highly dependent on the location, type
a n ds u b s e to ft h ec e l l[ 5 2 - 5 6 ] ,v a r y i n gr a t e so fn e u t r o -
phil infiltration are possibly at different neuroinflamma-
tory foci dictated by these complex interactions.
Conclusion
In conclusion, we have shown that concentrations of
CXCL1 and MIP-1a significantly increase in the brain
of rats following GD-induced SE. We have also identi-
fied specific cell types that express these factors; neu-
rons and endothelial cells primarily express CXCL1,
while neurons and dystrophic microglia primarily
express MIP-1a. Neutrophil infiltration significantly
increases in regions where CXCL1 and MIP-1a expres-
sion and neuronal death occur. Lastly, expression of
these chemokines precedes neutrophil infiltration, con-
sistent with their chemotactic properties, but infiltration
is not necessarily proportional to chemokine concentra-
tion. These data suggest a strong activation and recruit-
ment of neutrophils to areas of brain damage
modulated, at least partially, by CXCL1 and MIP-1a
expression by injured neurons, microglia and endothelial
cells following GD-induced SE.
List of abbreviations
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